Visit the Kratom Roundtable
The timely and positive response from the DEA
2nd CRE Letter to the DEA (September 12, 2016)
1sr CRE Letter to the DEA (September 8, 2016)
CRE has submitted a Request for Information to DEA regarding its listing of kratom as a Schedule I narcotic. The information so requested is the DEA letter to HHS as mentioned in the Federal Register which announced the aforementioned listing, which states:
The Administrator [DEA} transmitted notice of his intent to place mitragynine and 7-hydroxymitragynine in schedule I on a temporary basis to the Assistant Secretary[HHS] by letter dated May 6, 2016.
